Lantheus (LNTH)
(Delayed Data from NSDQ)
$64.41 USD
+0.61 (0.96%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $64.41 0.00 (0.00%) 7:02 PM ET
2-Buy of 5 2
A Value B Growth F Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
LNTH 64.41 +0.61(0.96%)
Will LNTH be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for LNTH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LNTH
Can Higher Visits Soften Cost Blow for Teladoc (TDOC) in Q1?
Why Lantheus Holdings (LNTH) is a Top Growth Stock for the Long-Term
LNTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Lantheus Holdings (LNTH) is a Top Growth Stock for the Long-Term
Is Lantheus (LNTH) Stock Undervalued Right Now?
Should You Buy Encompass Health (EHC) Ahead of Q1 Earnings?
Other News for LNTH
Why Lantheus Holdings Inc's Stock Skyrocketed 11% in a Quarter
Lantheus price target raised by $4 at B. Riley, here's why
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Johnson & Johnson (JNJ) and Lantheus (LNTH)
Buy Rating for Lantheus Holdings with Strong Growth and Acquisition Potential